Elucidating the exact pharmacological mechanism of motion (MOA) of Normally happening compounds is usually complicated. Even though Tarselli et al. (60) created the main de novo artificial pathway to conolidine and showcased that this Obviously occurring compound properly suppresses responses to each chemically induced and inflammation-derived pain